Effects of anxiogenic drugs on the emission of 22- and 50-kHz ultrasonic vocalizations in adult rats
- 137 Downloads
Adult rat 22-kHz vocalizations are often associated with alarm or distress, whereas a subset of 50-kHz calls is preferentially emitted in response to amphetamine and other rewarding stimuli. Whether any 50-kHz calls reflect anxiety is unknown.
To determine the effects of anxiogenic drugs on 50-kHz call rate and call subtype profile, in comparison with d-amphetamine.
Adult male rats received systemic amphetamine (1 mg/kg) three times several days before testing. Ultrasonic vocalizations were then recorded after acute intraperitoneal injection of amphetamine or one of five anxiogenic drugs: yohimbine (2.5 mg/kg), N-methyl-β-carboline-3-carboxamide (FG 7142, 5 mg/kg), pentylenetetrazol (PTZ, 20 mg/kg), m-chlorophenylpiperazine (mCPP, 1 mg/kg), caffeine (25 mg/kg), or vehicle.
The duration of immobility was increased by FG 7142, PTZ, and mCPP; this measure was unchanged by yohimbine and reduced by the locomotor stimulant drugs amphetamine and caffeine. Conversely, the 50-kHz call rate was reduced by FG 7142, PTZ and mCPP, and increased by caffeine and amphetamine. Overall, the most common 50-kHz call subtypes were flat, trill, step-up, and complex. Consistent with previous reports, amphetamine increased the relative prevalence of trill calls while reducing the relative prevalence of flat calls. Yohimbine and caffeine reduced flat call prevalence, whereas mCPP reduced trill call prevalence. No other shifts in the call profile were observed, and no anxiogenic drug induced 22-kHz calls.
Anxiogenic drugs, as a class, did not uniformly alter the 50-kHz call rate or subtype profile. Amphetamine-induced effects on 50-kHz call rate and profile do not reflect anxiety.
KeywordsUltrasonic vocalization Anxiety FG 7142 m-Chlorophenylpiperazine (mCPP) Anxiogenic Amphetamine
Supported by the Natural Science and Engineering Research Council of Canada (NSERC) discovery grant (155055, to P.B.S.C). P.B.S.C. is a member of the Center for Studies in Behavioral Neurobiology at Concordia University, Montreal.
The authors have no financial relationship with the organizations that sponsored this research.
Compliance with ethical standards
All experiments comply with the current laws of Canada.
- Bagdy G, Graf M, Anheuer ZE, Modos EA, Kantor S (2001) Anxiety-like effects induced by acute fluoxetine, sertraline or m-CPP treatment are reversed by pretreatment with the 5-HT2C receptor antagonist SB-242084 but not the 5-HT1A receptor antagonist WAY-100635. Int J Neuropsychopharmacol 4:399–408CrossRefPubMedGoogle Scholar
- Burgdorf J, Moskal JR (2010) Frequency modulated 50 kHz ultrasonic vocalizations reflect a positive emotional state in the rat: neural substrates and therapeutic implications. In: Brudzynski SM (ed) Handbook of mammalian vocalization. Elsevier, Amsterdam, pp 209–214Google Scholar
- Clarke PB, Wright J (2014) Rodent ultrasonic vocalizations. In: Stolerman IP, Price LH (eds) Encyclopedia of psychopharmacology. Springer, Berlin, Heidelberg, pp 1–8Google Scholar
- Good R (1940) Some observations of the psychological aspects of cardiazol therapy. Br J Psychiatry 86:491–501Google Scholar
- Mahler SV, Moorman DE, Feltenstein MW, Cox BM, Ogburn KB, Bachar M, McGonigal JT, Ghee SM, See RE (2013) A rodent "self-report" measure of methamphetamine craving? Rat ultrasonic vocalizations during methamphetamine self-administration, extinction, and reinstatement. Behav Brain Res 236:78–89CrossRefPubMedGoogle Scholar
- Panksepp J, Burgdorf J (2010) Laughing rats? Playful tickling arouses high-frequency ultrasonic chirping in young rodents. Am J Play 2:357–372Google Scholar
- Taracha E, Kaniuga E, Chrapusta SJ, Boguszewski PM, Lehner M, Krzascik P, Plaznik A (2014) N-Acetyl cysteine does not modify the sensitization of the rewarding effect of amphetamine as assessed with frequency-modulated 50-kHz vocalization in the rat. Behav Brain Res 280:141–148CrossRefPubMedGoogle Scholar
- Wöhr M, Schwarting RKW (2010) Rodent ultrasonic communication and its relevance for models of neuropsychiatric disorders. e-Neuroforum 4:71–80Google Scholar